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TO THE EDITOR
I read with great interest the article by
Hiscutt et al. (2010) entitled ‘‘X-Linked
Inhibitors of Apoptosis Protein as a
Therapeutic Target in Metastatic Mela-
noma.’’ The data presented indicate
that X-linked inhibitor of apoptosis
protein (XIAP) could serve as a target
to inhibit the growth of melanoma cells.
A key objective of the study was to
examine the relationship between XIAP
expression and mutations in N-RAS
and B-RAF. To achieve this goal, the
authors examined N-RAS and B-RAF
mutations in 49 melanoma samples and
found no correlation between muta-
tions in these genes and the expres-
sion of XIAP. This lack of correlation
may be due to the fact that the
49 melanoma samples were hetero-
geneous with respect to tumor type
and AJCC stage. Although the authors
mention that they did separate analyses
with AJCC stages Ib, II, and III, the
groups were still heterogeneous and did
not account for differences in tumor
type. For example, tumors of stage IIA,
IIB, and IIC from superficial spread-
ing malignant melanoma, nodular
malignant melanoma, and acral lenti-
ginous melanoma were all linked
together in the same analysis. This
heterogeneity could have masked an
association between XIAP expression
and mutations in N-RAS and B-RAF that
may be present in a particular AJCC
stage and tumor type. While I can
appreciate the difficulty in obtaining
enough samples for each tumor type
and AJCC stage, the conclusion that
there is no significant correlation bet
ween XIAP expression and mutations in
N-RAS and B-RAF is not justified.
Considering the limitations in ob-
taining sufficient samples of different
tumor types and AJCC stages, a better
way to establish a relationship between
N-RAS/B-RAF mutations and the ex-
pression of XIAP could be to study this
phenomenon in cell lines. This ap-
proach is feasible because, as the
authors have shown in Figure 1, this
protein is highly expressed in three of
the five cell lines that were evaluated.
Indeed, the authors used a knockdown
of XIAP in A375 cells to establish its
role in apoptosis. A similar approach
could have been used to examine
XIAP’s relationship with mutations in
N-RAS/B-RAF. Using this approach,
for example, the authors could have
obtained definitive answers on the
effect of V600E B-RAF mutations
on XIAP expression because selective
inhibitors of V600E B-RAF are available
(Flaherty et al., 2010).
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TO THE EDITOR
Tissue injury initiates a complex series
of events that act to restore tissue
structure and homeostasis. Infiltration
of inflammatory cells and vascular
remodeling are both keystones of this
process. However, the role of inflam-
mation and angiogenesis and particu-
larly the significance of vascular
endothelial growth factor (VEGF) in this
context are unclear. Studies of dermal
wound healing have delivered conflict-
ing results on the benefit of inflamma-
tory cell infiltration and release of
VEGF, in both wound closure and
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